Thyroid Medication Recall: Key Details on Affected Products

WHO:

USA Today - Major Rugby, a pharmaceutical manufacturer, is involved in the recall.

NBC 7 San Diego - Major Pharmaceuticals and Cardinal Health are also involved in the distribution of the recalled products.

WHAT:

USA Today - A nationwide recall was issued for 12 packages of levothyroxine sodium tablets.

USA Today - The recalled tablets are described as "subpotent," meaning they deliver less medication than intended.

NBC 7 San Diego - The FDA issued a Class II recall, indicating that the products "may cause temporary or medically reversible adverse health consequences."

WHERE:

USA Today - The recalled products were distributed nationwide.

WHEN:

USA Today - The recall was announced in a letter sent to retailers earlier in the month of July 2026.

NBC 7 San Diego - The FDA issued the recall on July 13, 2026.

USA Today - The recalled tablets were distributed beginning in January 2025.

WHY:

USA Today - The recall was initiated due to the tablets being "subpotent," which affects their effectiveness.

HOW:

USA Today - Consumers are urged to return the recalled medication to the point of purchase.

USA Today - Customers are advised to consult their doctor or physician if they find the recalled product in their medicine cabinet.

(UPDATED July 28, 2026 05:56 UTC)

A nationwide recall has been issued for twelve packages of levothyroxine sodium tablets due to concerns that they are "subpotent," meaning they deliver less medication than intended. Major Rugby, along with Cardinal Health, is involved in the distribution of these products, which were distributed across the country starting in January 2025. Consumers are urged to return the recalled medication to the point of purchase and should consult their doctor if they find the affected product in their medicine cabinet.